cGMP-Aligned · FDA-Registered U.S. Facility · Third-Party COA on Every LotSupplied for Research Use Only
BioRegenEx · Research

MSC Exosomes vs PRP: How They Differ and What the Research Shows

← Back to Research Library

Clinics exploring regenerative options often compare MSC-derived exosomes with platelet-rich plasma (PRP). Both are studied in regenerative research, but they are fundamentally different materials. This overview is for research and educational purposes only.

What each one is

PRP is prepared from a patient’s own blood, concentrating platelets and the growth factors they release. MSC-derived exosomes are nanoscale extracellular vesicles (roughly 30–150 nm) secreted by mesenchymal stem cells; they are cell-free and carry signaling cargo such as proteins, lipids, and microRNA. Exosomes are not stem cells and are supplied as an acellular product.

Key differences

  • Source: PRP is autologous (from the patient); MSC exosomes are produced from screened donor MSC lines and supplied as a characterized material.
  • Consistency: PRP composition varies patient-to-patient; characterized exosome lots are documented with a per-lot Certificate of Analysis.
  • Form: PRP contains cells and platelets; exosomes are cell-free vesicles.

What the research explores

Both are studied in preclinical and laboratory research for signaling involved in tissue repair and inflammation. The published MSC-exosome literature spans orthopedic, dermatologic, and other models — indexed in our Exosome Research Library. These are research findings, not evidence of a clinical treatment.

Sourcing considerations for clinics

If you are evaluating research-grade exosomes, look for characterization (particle size and concentration), sterility and endotoxin screening, cold-chain handling, and clear research-use-only labeling. See MSC exosomes in orthopedic research or partner with BioRegenEx to discuss research-use supply.

These statements have not been evaluated by the FDA. BioRegenEx supplies MSC-derived exosomes for research use only (RUO); they are not intended to diagnose, treat, cure, or prevent any disease. This content is educational and is not medical advice.

Important Information

These statements have not been evaluated by the U.S. Food and Drug Administration. BioRegenEx products are not intended to diagnose, treat, cure, or prevent any disease.

Exosome therapy is an emerging regenerative approach. It is investigational, outcomes vary, and individual results cannot be guaranteed. Patient testimonials reflect individual experiences and are not representative of typical results.

References to regulatory standards — including Section 351(a) of the Public Health Service Act — describe the company’s stated quality and compliance approach and should not be interpreted as FDA approval or endorsement of any product.

This presentation is provided for educational and informational purposes only and does not constitute medical advice. Treatment decisions should always be made in consultation with a qualified, licensed healthcare provider.